Oregon has quietly become ground zero in the fight over who controls hospitals and what patients pay. A new national ranking pegs the state as one of the most tightly consolidated hospital markets in the country, just as a headline-grabbing OHSU - Legacy merger went down in flames and lawmakers in Salem moved to curb corporate control of medical practices. For patients, employers, and insurers, that mix of big deals, regulatory muscle, and fresh law is reshaping how care is bought and sold across the state.
Yale ranking puts Oregon among the most concentrated states
According to a report by the Health Care Affordability Lab at Yale, roughly 72% of Oregon’s roughly 60 hospitals operate in highly concentrated markets or effectively as local monopolies. “One major and underappreciated factor driving price increases is rising consolidation among U.S. hospitals,” the lab wrote, and its interactive tool flags multiple Oregon markets where only a few hospital systems dominate. Economists say that kind of concentration can translate into higher prices and limited choice for patients, even when the care itself looks the same.
Big merger fight in Portland ended in a withdrawal
Plans for Oregon Health & Science University to acquire Legacy Health, a deal that would have tied Legacy’s eight hospitals and billions of dollars in assets to OHSU, were mutually abandoned in May 2025, according to OPB. The proposal sparked fierce public opposition and drew a community review board that advised regulators to reject the transaction over concerns it would raise prices. Both systems have reported operating losses in recent years, turning the stalled deal into a flashpoint over whether consolidation is a financial lifeline or a price-driving power grab.
Lawmakers tightened the rules on corporate control
State lawmakers followed up by passing aggressive limits on outside ownership and management structures in 2025. As outlined by Oregon Legislature records for Senate Bill 951, the law restricts how management-services organizations (MSOs) and non-licensed investors can own or control professional medical entities and voids certain noncompete and nondisclosure clauses. Supporters argue the bill helps preserve clinical autonomy for doctors and nurses. Critics warn it could make it harder for smaller or rural practices to attract capital or partner with outside groups.
Hospital prices are driving national spending
The push to limit consolidation is arriving as hospital spending has played an outsized role in rising health costs. An analysis by KFF found hospitals accounted for about 40% of the growth in national health spending between 2022 and 2024. Policy analysts say both higher prices and a rebound in service volume after the pandemic explain much of the increase. That makes market structure a key lever for anyone trying to rein in premiums and out-of-pocket costs.
Enforcement gap helps consolidation persist
The Yale lab also highlights what it calls an enforcement gap. Roughly 1,300 hospital mergers have taken place since 2000 among about 5,000 hospitals nationwide, yet federal agencies intervened in only a small fraction of those deals, according to the lab. Its state-by-state tool flags six “red zone” mergers tied to Oregon markets that are likely to raise post-merger concentration and, with it, pressure on prices. That combination of local consolidation and limited federal action is a big reason states like Oregon are experimenting with new laws and oversight programs.
What regulators can do
Oregon’s Health Care Market Oversight program can review major transactions and disapprove those it finds are not in the public interest, a process that played out during the OHSU - Legacy review, per OPB. Advocates say tougher state review and clearer ownership rules can help block mergers that mainly serve to boost prices. Industry groups counter that if the rules are too tight, struggling hospitals could be left without viable partners. Those trade-offs are now front and center in policy debates in Salem and beyond.
For Oregon patients, the new Yale ranking and national spending data serve as a reminder that market structure matters, influencing wait times, provider choice, and what care ultimately costs. Whether Oregon’s new laws and watchdog reviews will actually slow price growth is still an open question, but the state’s moves are shaping up as a test case for others wrestling with hospital consolidation.
